194 related articles for article (PubMed ID: 16289318)
1. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline passes through the blood-brain barrier of rat brain: an in vivo microdialysis study.
Song Y; Feng Y; Leblanc MH; Castagloni N; Liu YM
Neurosci Lett; 2006 Feb; 395(1):63-6. PubMed ID: 16289318
[TBL] [Abstract][Full Text] [Related]
2. Capillary liquid chromatography-tandem mass spectrometry of tetrahydroisoquinoline derived neurotoxins: a study on the blood-brain barrier of rat brain.
Song Y; Xu J; Hamme A; Liu YM
J Chromatogr A; 2006 Jan; 1103(2):229-34. PubMed ID: 16310796
[TBL] [Abstract][Full Text] [Related]
3. Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum.
Katagiri N; Abe K; Kitabatake M; Utsunomiya I; Horiguchi Y; Hoshi K; Taguchi K
Neuroscience; 2009 Jun; 160(4):820-8. PubMed ID: 19285542
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin extracellular pharmacokinetics and concurrent gamma-aminobutyric acid neurotransmitter effects in rat frontal cortex and hippocampus using microdialysis.
Tong X; Ratnaraj N; Patsalos PN
Epilepsia; 2009 Feb; 50(2):174-83. PubMed ID: 19016829
[TBL] [Abstract][Full Text] [Related]
5. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
[TBL] [Abstract][Full Text] [Related]
6. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
Boström E; Simonsson US; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
[TBL] [Abstract][Full Text] [Related]
7. Application of triple-probe microdialysis for fast pharmacokinetic/pharmacodynamic evaluation of dopamimetic activity of drug candidates in the rat brain.
Weikop P; Egestad B; Kehr J
J Neurosci Methods; 2004 Dec; 140(1-2):59-65. PubMed ID: 15589335
[TBL] [Abstract][Full Text] [Related]
8. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain.
Sun H; Bungay PM; Elmquist WF
J Pharmacol Exp Ther; 2001 Jun; 297(3):991-1000. PubMed ID: 11356921
[TBL] [Abstract][Full Text] [Related]
9. Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats.
Song P; Ma F; Wang F; Wang X; Patil R; Ramagiri S; Orr WE; Miller DD; Geisert E; Yates CR
Cancer Chemother Pharmacol; 2008 May; 61(6):1037-44. PubMed ID: 17768626
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier penetration of novel pyridinealdoxime methiodide (PAM)-type oximes examined by brain microdialysis with LC-MS/MS.
Okuno S; Sakurada K; Ohta H; Ikegaya H; Kazui Y; Akutsu T; Takatori T; Iwadate K
Toxicol Appl Pharmacol; 2008 Feb; 227(1):8-15. PubMed ID: 17964625
[TBL] [Abstract][Full Text] [Related]
11. Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.
Xie R; Bouw MR; Hammarlund-Udenaes M
Br J Pharmacol; 2000 Dec; 131(8):1784-92. PubMed ID: 11139459
[TBL] [Abstract][Full Text] [Related]
12. Blood and cerebral concentrations of the new potential analgesic UP 26-91 measured in vivo by microdialysis after toxic doses.
Bouër R; Saivin S; Malmary MF; Hermann P; Poey J; Houin G
Arzneimittelforschung; 1998 Jul; 48(7):745-9. PubMed ID: 9706375
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the high partition of YM992, a novel antidepressant, in rat brain - in vitro and in vivo evidence for the high binding in brain and the high permeability at the BBB.
Mano Y; Higuchi S; Kamimura H
Biopharm Drug Dispos; 2002 Dec; 23(9):351-60. PubMed ID: 12469328
[TBL] [Abstract][Full Text] [Related]
14. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
Wąsik A; Romańska I; Antkiewicz-Michaluk L
Neurotox Res; 2016 Nov; 30(4):648-657. PubMed ID: 27568335
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-based in vivo investigation on blood-brain barrier permeability following ischemia and reperfusion.
Yang CS; Chang CH; Tsai PJ; Chen WY; Tseng FG; Lo LW
Anal Chem; 2004 Aug; 76(15):4465-71. PubMed ID: 15283589
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
Bundgaard C; Jørgensen M; Larsen F
Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
[TBL] [Abstract][Full Text] [Related]
18. Microdialysis evaluation of atomoxetine brain penetration and central nervous system pharmacokinetics in rats.
Kielbasa W; Kalvass JC; Stratford R
Drug Metab Dispos; 2009 Jan; 37(1):137-42. PubMed ID: 18936112
[TBL] [Abstract][Full Text] [Related]
19. Determination of baicalin in rat cerebrospinal fluid and blood using microdialysis coupled with ultra-performance liquid chromatography-tandem mass spectrometry.
Huang H; Zhang Y; Yang R; Tang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):77-83. PubMed ID: 18805743
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
